The introduction of microarray techniques to cancer research brought great expectations for finding biomarkers that would improve patients treatment; however, the results of such studies are poorly reproducible, and critical analyses of these methods are rare. In this study we examined gene expression in 97 ovarian cancer samples. Validation of results by quantitative RT-PCR was performed also on 30 additional ovarian cancer samples. We carried out a number of systematic analyses in relation to several defined clinicopathological features. The main goal of our study was to delineate the molecular background of ovarian cancer chemoresistance and find biomarkers suitable for prediction of patients prognosis. Histological tumor type was the ma...
BACKGROUND: Germline mutations in BRCA1 and BRCA2 are responsible for 5%-10% of epithelial ovarian c...
Ovarian cancer is a common cause of death among women worldwide. The current diagnostic and prognost...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Microarray-based gene expression studies demonstrate that ovarian cancer is both a clinically divers...
Microarray-based gene expression studies demonstrate that ovarian cancer is both a clinically divers...
Microarray-based gene expression studies demonstrate that ovarian cancer is both a clinically divers...
Background Human epithelial ovarian cancer cell line SKOV3.ip1 is more invasive and metastatic compa...
SummaryBackgroundHuman ovarian carcinoma is a silent killer. Most patients with human ovarian carcin...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
BACKGROUND: Germline mutations in BRCA1 and BRCA2 are responsible for 5%-10% of epithelial ovarian c...
Ovarian cancer is a common cause of death among women worldwide. The current diagnostic and prognost...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and cli...
Microarray-based gene expression studies demonstrate that ovarian cancer is both a clinically divers...
Microarray-based gene expression studies demonstrate that ovarian cancer is both a clinically divers...
Microarray-based gene expression studies demonstrate that ovarian cancer is both a clinically divers...
Background Human epithelial ovarian cancer cell line SKOV3.ip1 is more invasive and metastatic compa...
SummaryBackgroundHuman ovarian carcinoma is a silent killer. Most patients with human ovarian carcin...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
BACKGROUND: Germline mutations in BRCA1 and BRCA2 are responsible for 5%-10% of epithelial ovarian c...
Ovarian cancer is a common cause of death among women worldwide. The current diagnostic and prognost...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...